Physician profile
Ebenezer Enchia
NPI 1417305558
$983.15
in general payments reported to CMS, 2019-2025
15 companies · $375 in 2025
The $375 reported for 2025 was more than what 80% of Preventive Medicine/Occupational Environmental Medicine providers received nationally (typical 2025 total: $76.00).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $342 · 2024: $267 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $309.58 | 2023-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $147.15 | 2024-2025 | Wegovy |
| Lilly USA, LLC | $93.00 | 2023-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $83.58 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Medtronic, INC. | $54.56 | 2023-2025 | Minimed 780g |
| Beta Bionics, INC. | $46.59 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Exact Sciences Corporation | $42.64 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Corcept Therapeutics | $42.25 | 2025 | Korlym |
| Dexcom, INC. | $38.89 | 2024-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $25.83 | 2025 | |
| Xeris Pharmaceuticals, INC. | $22.10 | 2023 | Gvoke Hypopen |
| Axonics, INC. | $21.94 | 2023 | Axonics |
| Lundbeck LLC | $21.81 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.23 | 2025 | Jardiance |
| Inspire Medical Systems, INC. | $15.00 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ebenezer Enchia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.